Buscar
Mostrando ítems 1-10 de 23
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases
For two centuries, vaccines have been successful in the fight against viruses, triggering immune protection. Indeed, the elimination of smallpox, the only infectious disease eradicated to date, was made possible through ...
Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation
(SOC CHILENA INFECTOLOGIA, 2012)
CMV is one of the main infectious problems for SOT and HSCT. The severity of the complications are mainly associated with the type of transplant and immune status against the virus of the transplant donor and the transplant ...
Real-Time PCR in HIV/Trypanosoma cruzi Coinfection with and without Chagas Disease Reactivation: Association with HIV Viral Load and CD4(+) Level
(PUBLIC LIBRARY SCIENCE, 2011)
Background: Reactivation of chronic Chagas disease, which occurs in approximately 20% of patients coinfected with HIV/Trypanosoma cruzi (T. cruzi), is commonly characterized by severe meningoencephalitis and myocarditis. ...
Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients
(W B Saunders Co LtdLondonInglaterra, 2005)
Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene
(Int Medical Press LtdLondonInglaterra, 2012)
Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in chile
(2009)
Background. Cytomegalovirus (CMV) infection remains as an important cause of morbidity and mortality in children undergoing hematopoietic stem cell transplantation (HSCT). Our aim was to assess the incidence, risk factors, ...
Risk factors for Chagas` disease reactivation after heart transplantation
(ELSEVIER SCIENCE INC, 2008)
Background: Chagas` disease is the illness caused by the protozoan Trypanosoma cruzi and it is still endemic in Latin America. Heart transplantation is a therapeutic option for patients with end-stage Chagas` cardiomyopathy. ...